Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents

Myxoid Liposarcomas (MLS), characterized by the expression of FUS‐CHOP fusion gene are clinically very sensitive to the DNA binding antitumor agent, trabectedin. However, resistance eventually occurs, preventing disease eradication. To investigate the mechanisms of resistance, a trabectedin resistan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2012-07, Vol.131 (1), p.59-69
Hauptverfasser: Uboldi, S., Bernasconi, S., Romano, M., Marchini, S., Fuso Nerini, I., Damia, G., Ganzinelli, M., Marangon, E., Sala, F., Clivio, L., Chiorino, G., Giandomenico, S. Di, Rocchi, M., Capozzi, O., Margison, G.P., Watson, A.J., Caccuri, A.M., Pastore, A., Fossati, A., Mantovani, R., Grosso, F., Tercero, J.C., Erba, E., D'Incalci, M.
Format: Artikel
Sprache:eng
Schlagworte:
DNA
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!